Mechanisms of p53 degradation

被引:111
作者
Chao, Chuck C. -K. [1 ,2 ]
机构
[1] Chang Gung Univ, Coll Med, Dept Biochem & Mol Biol, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 333, Taiwan
关键词
De-ubiquitinating enzyme; E3; ligase; Mdm2; p53; Proteasome; Ubiquitin; UBIQUITIN-PROTEIN LIGASE; PROTEASOME-MEDIATED DEGRADATION; NERVOUS-SYSTEM DEVELOPMENT; SENSITIZES CANCER-CELLS; TUMOR-SUPPRESSOR P53; IN-VIVO; REGULATE P53; TRANSCRIPTIONAL ACTIVITY; DEUBIQUITINATING ENZYME; CDT1; PROTEOLYSIS;
D O I
10.1016/j.cca.2014.08.015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The tumor suppressor p53 plays various functional roles in the cell by regulating multiple regulatory signals that ensure adequate temporal and spatial responses to cellular stress. p53 is usually kept inactive due to ubiquitination by a number of E3 ubiquitin ligases that target p53 for proteasomal degradation. The ubiquitously expressed proto-oncogene Mdm2 is the major E3 ubiquitin ligase involved in this process and is critical for regulating p53 homeostasis. Ubiquitination by E3 ligases may induce cellular relocation of p53 and determine the outcome of p53-mediated stress response, including cell proliferation, apoptosis and efficacy of cancer therapy. In addition to marking p53 for proteasomal degradation, ubiquitination acts as a signal for the degradation-independent functions of p53, such as nuclear export and transcriptional activation. Importantly, the reversible nature of the ubiquitination process and the identification of de-ubiquitination enzymes acting on p53 have added yet another layer of regulatory mechanism controlling p53 activity. This review highlights our current understanding of the mechanisms underlying p53 degradation as well as the significance of the p53 pathway in response to genotoxic stress. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
[41]   Redox Modulation of p53: Mechanisms and Functional Significance [J].
Kim, Do-Hee ;
Kundu, Joydeb Kumar ;
Surh, Young-Joon .
MOLECULAR CARCINOGENESIS, 2011, 50 (04) :222-234
[42]   Mechanisms of switching on p53: a role for covalent modification? [J].
Meek, DW .
ONCOGENE, 1999, 18 (53) :7666-7675
[43]   A Chimeric p53 Evades Mutant p53 Transdominant Inhibition in Cancer Cells [J].
Okal, Abood ;
Mossalam, Mohanad ;
Matissek, Karina J. ;
Dixon, Andrew S. ;
Moos, Philip J. ;
Lim, Carol S. .
MOLECULAR PHARMACEUTICS, 2013, 10 (10) :3922-3933
[44]   Proteolytic cleavage of p53: A model for the activation of p53 in response to DNA damage [J].
Okorokov, AL ;
Milner, J .
ONCOLOGY RESEARCH, 1997, 9 (6-7) :267-273
[45]   Effects of Chronic Ochratoxin A Exposure on p53 Heterozygous and p53 Homozygous Mice [J].
Bondy, Genevieve S. ;
Caldwell, Donald S. ;
Aziz, Syed A. ;
Coady, Laurie C. ;
Armstrong, Cheryl L. ;
Curran, Ivan H. A. ;
Koffman, Robyn L. ;
Kapal, Kamla ;
Lefebvre, David E. ;
Mehta, Rekha .
TOXICOLOGIC PATHOLOGY, 2015, 43 (05) :715-729
[46]   Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation [J].
Hengstermann, A ;
Whitaker, NJ ;
Zimmer, D ;
Zentgraf, H ;
Scheffner, M .
ONCOGENE, 1998, 17 (22) :2933-2941
[47]   Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53 [J].
Xirodimas, DP ;
Stephen, CW ;
Lane, DP .
EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) :66-77
[48]   Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation [J].
Arnd Hengstermann ;
Noel J Whitaker ;
Dagmar Zimmer ;
Hanswalter Zentgraf ;
Martin Scheffner .
Oncogene, 1998, 17 :2933-2941
[49]   A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway [J].
Brignone, C ;
Bradley, KE ;
Kisselev, AF ;
Grossman, SR .
ONCOGENE, 2004, 23 (23) :4121-4129
[50]   A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway [J].
Chrystelle Brignone ;
Kathleen E Bradley ;
Alexei F Kisselev ;
Steven R Grossman .
Oncogene, 2004, 23 :4121-4129